The COVID-19 pandemic has magnified systemic failures across health care locally and globally—from depleted public health infrastructures, fragmented delivery systems, and unacceptable outcome disparities. Ariadne Labs has been focused on developing evidence-based solutions to support clinicians, patients, the general public, and public health decision-makers. Our COVID-19 response builds on our core strengths—the ability to quickly convene, converge, and gather best ideas and practices; design and test guidelines and tools; and then strategically disseminate them as widely as possible through the many channels available to us.
Focus Areas
Supporting systems to deliver vaccines with speed, scale, and equity as supply and demand shift over time.
LEARN MORE
Focusing on communicating simple, easy to use information for the general public to mitigate the exposure and spread of COVID-19.
LEARN MORE
A global response can aid in ensuring equitable, efficient COVID-19 responses.
LEARN MORE
Innovating around the impacts of COVID-19 on obstetric services from prenatal, labor and delivery, and postnatal care.
LEARN MORE
Resources for patients and providers to offer guidance and best practices to ensure safe, effective outpatient care.
LEARN MORE
Resources to help health systems and providers navigate the impact of COVID-19 to ensure the safety of patients and the health care workforce.
LEARN MORE
Tools and resources for adults over the age of 65 and those with pre-existing health risks who at higher risk of severe illness from COVID-19.
LEARN MOREHighlights
Six states and one U.S. territory selected to assess feasibility of integrating whole genome sequencing into public health newborn screening Boston, MA Investigators leading BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening) today announced two major milestones in an NIH-funded research effort to evaluate genomic newborn screening: the selection of participating state… Continue reading BEACONS Selects Seven Sites, Finalizes Gene List for Genomic Newborn Screening Study
After a surgery in 2022, Carl developed an infection. He was told treatment would require a 10-day hospital stay, and he was dreading the long days of beeping machines, interrupted sleep, and mediocre food. So when he learned that he qualified for the hospital’s newly launched Rural Home Hospital Program, he was thrilled. Carl could… Continue reading Solving the Rural Health Crisis: Care from the Comfort of Home
Dr. Asaf Bitton pens a call to action published by the Millbank Memorial Fund on his vision of a “triple double” for primary care by 2030.